Paediatrica Indonesiana Original Article Comparative efficacy of artesunate and sulphadoxine-pyrimethamine combination with artesunate and amodiaquine combination in uncomplicated falciparum malaria in children Jose Meky Mandei, Novie Homenta Rampengan, Suryadi Nicolaas, Napoleon Tatura, Ari Lukas Runtunuwu, Tony Homenta Rampengan Abstract Conclusion The combination of artesunate and sulpha- Background Malaria is still an important cause of mortality
doxine-pyrimethamine and combination of artesunate
and morbidity in children and adults in tropical countries.
and amodiaquine were found to be equally effective in the
Multidrug resistance againts chloroquine and sulphadox-
treatment of uncomplicated falciparum malaria in children
ine-pyrimethamine had brought to an introduction of
[Paediatr Indones 2008;48:240-5].
artemisinin-based combination. Objective To assess the alternative treatment of uncompli- Keywords: uncomplicated falciparum malaria, arte-
cated falciparum malaria in children using artesunate and
sunate, sulphadoxine-pyrimethamine, amodiaquine.
sulphadoxine-pyrimethamine combination comparing to artesunate and amodiaquine combination. Methods This is a single-blind randomized trial. Sixty- VHYHQFKLOGUHQDJHGVL[PRQWKVWR\HDUVZHUHUHFUXLWHG 7KLUW\WKUHHFKLOGUHQZHUHWUHDWHGZLWKDUWHVXQDWHPJ
Malaria is an important cause of mortality
NJEZGD\IRUWKUHHGD\VZLWKDQDGGLWLRQDOVXOSKDGR[LQH
S\ULPHWKDPLQH S\ULPHWKDPLQH PJNJEZ VLQJOH
PLOOLRQLQGLYLGXDOVDUHLQIHFWHG
GRVHRQWKHILUVWGD\ZKLOHFKLOGUHQZHUHWUHDWHGZLWK
ZLWK PDODULD HYHU\ \HDU ZKHUH PLOOLRQ RI WKHP
DUWHVXQDWHDQGDPRGLDTXLQHEDVHPJNJEZGD\IRUWKH
lived in highly endemic area in Africa. Infection due
ILUVWWZRGD\VWKHQPJNJEZGD\RQWKHWKLUGGD\%RG\
temperature and parasite count were recorded everyday for at least seven days. The outcomes were fever clearance time, parasite clearance time, cure rate and side effects. Sta-
From the Department of Child Health, Medical School, Sam Ratulangi
tistical analysis was performed using the student t-test. Results The statistical analysis showed that there were no difference between these two groups either in fever Reprint request to: Jose Meky Mandei, MD, Department of Child Health, Medical School, Sam Ratulangi University, Prof. R.D. Kandou General
FOHDUDQFH WLPH 3! RU LQ SDUDVLWH FOHDUDQFH WLPH
+RVSLWDO-O5D\D7DQDZDQJNR0DQDGR,QGRQHVLD7HOS
3!7KHFXUHUDWHZDVLQERWKJURXSV9RPLW-
ing was found in one patient treated with artesunate and
240Paediatr Indones, Vol. 48, No. 4, July 2008 Jose Meky Mandei et al: Artesunate and sulphadoxine-pyrimethamine vs artesunate and amodiaquine in falciparum malaria
WRPDODULDFDXVHVDQHVWLPDWLRQRIRQHWRPLOOLRQ
This study assessed the alternative treatment for
morbidity worldwide each year, mainly in tropical
uncomplicated falciparum malaria in children using
developing countries. ,Q ,QGRQHVLD PLOOLRQ
artesunate and sulphadoxine-pyrimethamine combi-
malaria cases were reported with annual death of
nation compared with artesunate and amodiaquine
,W LV HVWLPDWHG WKDW RI WKH ,QGRQHVLD
population live in a high risk area to be infected with malaria.
Most malaria-associated deaths are due to
Plasmodium falciparum FKLOGUHQ XQGHU WKH DJH RI
five and non-immune travelers are especially vul-
This study was a single-blind randomized trial.
nerable to severe infection. Falciparum malaria is
Subjects were uncomplicated falciparum malaria
an acute or chronic infection caused by Plasmodium
patients admitted to Prof. R. D. Kandou General
falciparum, characterized by recurrent fever, anemia
+RVSLWDO0DQDGRVLQFH1RYHPEHUXQWLO0DUFK
and hepatosplenomegaly.4,5 The diagnosis of malaria is
7KHVWXG\ZDVDSSURYHGE\(WKLFV&RPPLWWHHRI
established by clinical manifestations and identifica-
Prof. R.D. Kandou General Hospital, Manado.
tion of parasites on peripheral blood patients.6-8
The inclusion criteria were uncomplicated falci-
Malaria infection rate had been increasing in re-
SDUXPPDODULDSDWLHQWVDJHGVL[PRQWKVWR\HDUVROG
cent years and its treatment has been hampered by the
ZLWKKLVWRU\RIIHYHUoC) in more than 48 hours,
increasingly resistance of the parasites to antimalarial
P. falciparum monoinfection on thick blood film, no his-
drugs. Chloroquine and sulphadoxine-pyrimethamine
tory of allergic reaction to the study drug, no history of
resistance in falciparum malaria is well advanced, many
treatment with artesunate, amodiaquine, sulphadoxine-
patients treated with these will not benefits from the
pyrimethamine or other antibiotics act as antimalarial
treatment and sometimes even die.9 According to Pedo-
ZLWKLQWKHSDVWGD\VDQGZKRVHSDUHQWVRUJXDUGLDQ
man Penatalaksanaan Kasus Malaria di Indonesia in year of
had given a written informed consent. We excluded
WKHILUVWOLQHWUHDWPHQWRIXQFRPSOLFDWHGIDOFLSDU-
severely sick patients with (not able to drink, severe
um malaria is artesunate and amodiaquine combination
YRPLWLQJPRUHWKDQWZLFHZLWKLQSUHYLRXVKRXUV
plus primaquine.In Indonesia, the first report of chlo-
repeated generalized convulsion, lethargy or uncon-
roquine resistance in falciparum malaria was from East
scious state), severe malnutrition, and any evidence
.DOLPDQWDQLQ8QWLOFKORURTXLQHUHVLVWDQFH
of chronic disease or other acute infection.
was only in East Kalimantan and Irian Jaya. Since that,
Drop out was defined as termination from the
many provinces in Indonesia reported chloroquine re-
study due to any reason such as repeated vomiting,
sistance. The first report sulphadoxine-pyrimethamine
unable to consume drug orally, hypersensitivity reac-
resistance in falciparum malaria was from Irian Jaya. Study
tion, worsening of the condition, evidence of mixed
LQ 0DQDGR -DQXDU\ ² 'HFHPEHU IRXQG
infection on follow-up, or patient moved to other area.
resistance II (R II) to sulphadoxine-pyrimethamine
Patients who failed to respond the given treatment
(FansidarRLQILYHSDWLHQWVIURPSDWLHQWV
ZHUH WUHDWHG ZLWK TXLQLQH ZLWK WKH GRVH RI PJ
Rampengan et al from their study, found resistance II
Uncomplicated falciparum malaria was defined
Started from all the facts mentioned, an alterna-
as patient with falciparum malaria without complica-
tive antimalarial drugs to treat and prevent resistance
tion and do not fit the criteria of severe malaria from
to Plasmodium falciparum is needed. Plasmodium
WHO. Parasite count was measured as the number
falciparum resistance had reported from almost all
RISDUDVLWHVSHUOHXNRF\WHVRQDWKLFNEORRGILOP
antimalarial, except artemisinin and its derivates.
DVVXPLQJDWRWDOOHXNRF\WHVFRXQWRIO2QO\
Recently WHO formulated a policy that elevates
asexual parasites were measured (schizon, trophozoid
combination antimalarial therapy to preferred first
or ring forms), while gametocytes were not measured.
therapy for all malaria infections in areas where
Fever clearance time was defined as the time taken
Plasmodium falciparum is the predominant infecting
IRU D[LOODU\·V WHPSHUDWXUH WR IHOO EHORZ oC and
UHPDLQHG IRU DW OHDVW KRXUV 3DUDVLWH FOHDUDQFH
Paediatr Indones, Vol. 48, No. 4, July 2008241 Jose Meky Mandei et al: Artesunate and sulphadoxine-pyrimethamine vs artesunate and amodiaquine in falciparum malaria
time was defined as the time taken for clearance of
during study period. Seventy-one falciparum malaria
asexual parasites from peripheral blood film detectable
patients were enrolled and randomly allocated into
by microscope and remained cleared during follow-up
period. Resistance was defined as absence of asexual
Thirty-three children were treated with artesu-
parasitaemia RQGD\UHDSSHDULQJRQGD\HDUO\
nate and sulphadoxine-pyrimethamine combination
5,RURQGD\ODWH5,UHGXFWLRQLQDVH[XDO
DQG FKLOGUHQ ZHUH WUHDWHG ZLWK DUWHVXQDWH DQG
parasitaemiaEHORZRIGD\FRXQWRQGD\ZLWK
amodiaquine. Tables 1, 2, and 3 show that the demo-
asexual parasitaemiaRQGD\5,,SDUDVLWHVGHQVLW\
JUDSKLFFOLQLFDODQGODERUDWRU\GDWDRIWKHJURXSV
On admission, a standardized medical history
&XUHUDWHRQWKHWZRJURXSVZDV2Q
was taken and clinical examination performed. The
day seven, there was no parasites found in these two
children were weighed, axillary temperatures taken,
groups. No serious side effects during seven days
and capillary blood specimen was taken by venipunc-
observation in the two groups. Only one child had
ture for malaria films, hemoglobin, leukocyte, hema-
repeated vomiting after consuming artesunate and
tocrit, platelet, and liver function test (ALT, AST).
Enrolled patients were randomly assigned to either receive artesunate and sulphadoxine-pyrimethamine combination (group I) or artesunate and amodiaquine
Table 12CVKGPVUFKUVTKDWVKQPCEEQTFKPIEJCTCEVGTKUVKEUQHUWDLGEVU CPFITQWRU
combination (group II). Doses were given according to
ERG\ZHLJKWDUWHVXQDWHPJNJEZGD\IRUGD\VDQG
VXOSKDGR[LQHS\ULPHWKDPLQHS\ULPHWKDPLQH
PJNJEZVLQJOHGRVHRQWKHILUVWGD\IRUJURXS,DQG
DUWHVXQDWHPJNJEZGD\IRUGD\VDQGDPRGLDTXLQH
EDVHPJNJEZGD\IRUWKHILUVWGD\VWKHQPJ
NJEZGD\RQWKHWKLUGGD\IRUJURXS,,$OOGRVHVZHUH
directly observed and repeated if vomiting occurred
ZLWKLQPLQXWHV$IWHUWUHDWPHQWRQGD\FKLOGUHQ
were assessed clinically and parasitologically on day
Table 22CVKGPVUFKUVTKDWVKQPDCUGFQPENKPKEOCPKHGUVCVKQPUCPF
WR%RG\WHPSHUDWXUHVZHUHPHDVXUHGRQ
DQGHDFKGD\3DUDVLWHFRXQWZDV
#TVGUWPCVG52 #TVGUWPCVG#OQFKCSWKPG
'DWD ZHUH DQDO\]HG XVLQJ 6366 YHUVLRQ
Statistical analysis was performed using the student
Eighty-three falciparum malaria patients were admitted
in Prof. R. D. Kandou General Hospital, Manado
Table 3.CDQTCVQT[ſPFKPIUQPCFOKUUKQP 242Paediatr Indones, Vol. 48, No. 4, July 2008 Jose Meky Mandei et al: Artesunate and sulphadoxine-pyrimethamine vs artesunate and amodiaquine in falciparum malaria
Discussion
nate and sulphadoxine-pyrimethamine combination appeared slightly more efficacious than artesunate
The characteristics of both groups in this study were in
and amodiaquine combination. Koram et alfound
general similar. In general the clinical manifestations
that artesunate and lumefantrin combination (Coar-
and laboratory findings were similar to that previously
tem) and artesunate and amodiaquine combination
had rapid parasite clearance time than using single
After treatment, in artesunate and sulphadox-
antimalarial (chloroquine alone or sulphadoxine-
ine-pyrimethamine combination group had fever
clearance time shorter than in artesunate and amo-
Cure rates on day seven in both artesunate
diaquine combination group. Although this study
and sulphadoxine-pyrimethamine combination
had a difference on fever clearance time, but there
and artesunate and amodiaquine combination were
was no statistically difference between the two groups
HTXDO3DUDVLWHVHQVLWLYLW\FOLQLFDODQGSDUD-
3!7KLVILQGLQJVKRZVWKDWERWKDUWHVXQDWH
sitology responses were classified based on WHO.
and sulphadoxine-pyrimethamine combination and
From this classification, this study concluded that
artesunate and amodiaquine combination had rapid
these two artemisinin-based combination therapies
elimination of fever in falciparum malaria patients.
were equally efficacious in therapy uncomplicated
Van den Broek et alfound rapid elimination of fever
falciparum malaria in children. Guthmann et al26
o&DWGD\RQHDQGGD\WZRZDVDQG
found that the very low proportion of failures in
LQWKHDUWHVXQDWHDQGDPRGLDTXLQHFRPELQD-
both artesunate and sulphadoxine-pyrimethamine
WLRQJURXSDQGDQGLQWKHDUWHVXQDWHDQG
combination and artesunate and amodiaquine com-
sulphadoxine-pyrimethamine combination group,
bination than amodiaquine alone or sulphadoxine-
and on day three all but one (in artesunate and sul-
phadoxine-pyrimethamine combination group) were
Side effects during seven days observation in the
free from fever. Tambajongin her study found that
two groups occurred in one child, in artesunate and
the fever had decreased rapidly in artemisinin group
amodiaquine combination group. She had vomited
(artemeter). Dorsey et al found significant decrease
PLQXWHVDIWHUFRQVXPLQJWKHVHGUXJVDQGWKHQWKH
of fever in malaria patients which used artesunate
drugs were given again but then she vomited again.
and sulphadoxine-pyrimethamine combination and
Those drugs were changed to other antimalarial
artesunate and amodiaquine combination than using
(quinine sulphate) via nasogastric tube. This side
sulphadoxine-pyrimethamine alone. Koram et al
effect maybe caused by amodiaquine which is in the
on their study in Ghana, found that artesunate and
combination of the drugs. Amodiaquine was an anti-
lumefantrin combination (Coartem) and artesu-
malarial 4-aminoquinolines group which its structure
nate and amodiaquine combination had rapid fever
and activity is equal to chloroquine. This drug had
elimination than those using chloroquine alone or
equal side effect to chloroquine including nausea and
vomiting. Dorsey et alon their study in Uganda
Although there was difference in parasite clear-
RQFKLOGUHQZLWKXQFRPSOLFDWHGfalciparum ma-
ance time in this study, but there was no statistically
laria which treated with sulphadoxine-pyimrthamine
GLIIHUHQFH EHWZHHQ WKLV WZR JURXSV 3! 7KLV
alone, combination with artesunate or amodiaquine,
result shows that therapy for the uncomplicated
found no patients had severe side effect and less than
falciparum malaria patients used artesunate and
YRPLWHG 7KH VHUXP FRQFHQWUDWLRQ RI DPRGL-
sulphadoxine-pyrimethamine combination and arte-
aquine, artesunate or sulphadoxine-pyrimethamine
sunate and amodiaquine combination were equally
was not measured in this study from the start, this
efficacious on parasite clearance time. Tambajong
found parasite clearance time were more rapid in
We conclude that artesunate and sulphadoxine-
artemisinin-based combination therapy than without
pyrimethamine combination and artesunate and
using that combination. Van den Broek et al in Su-
amodiaquine combination was found equally effective
dan, who also used the same combination in his study,
in treatment of uncomplicated falciparum malaria in
found rapid parasite clearance time. However, artesu-
Paediatr Indones, Vol. 48, No. 4, July 2008243 Jose Meky Mandei et al: Artesunate and sulphadoxine-pyrimethamine vs artesunate and amodiaquine in falciparum malaria
Acknowledgments
falciparum malaria in Africa children. Am J Trop Med Hyg
The authors would like to thanks to Director and Ethics
9RQ6HLGOHLQ/0LOOLJDQ33LQGHU0%RMDQJ.$Q\DOHEHFKL
Committee of Prof. R.D. Kandou General Hospital, all patients
C, Gosling R, et al. Efficacy of artesunate plus pyrimethamine-
sulphadoxine for uncomplicated malaria in Gambian children: double-blind, community-randomised, placebo FRQWUROOHGWULDO/DQFHW
References
6LOLWRQJD.5DPSHQJDQ7+&RPSDUDWLYHHIILFDF\RIFRPEL-
nation fansidar-sulphat quinine and fansidar-HCl tetracycline
:RUOG +HDOWK 2UJDQL]DWLRQ *XLGHOLQHV IRU WUHDWPHQW RI
in falciparum malaria in children above 7 years old. Pediatr
'HSDUWHPHQ .HVHKDWDQ 5HSXEOLN ,QGRQHVLD 'LUHNWRUDW
6RZXQPL $ )DODGH $* $GHGHML $$ $\HGH $, 91
Jenderal Pemberantasan Penyakit Menular dan Penyehatan
Ndikum, CO Suwunmi, et al. Comparative Plasmodium
Lingkungan. Pedoman penatalaksanaan kasus malaria di
falciparum kinetics during treatment with amodiaquine and
FKORURTXLQHLQFKLOGUHQ&OLQ'UXJ,QYHVW6XSSO
)LOOHU6&DXVHU/01HZPDQ5'%DUEHU$05REHUWV-0
0DF$UWKXU-HWDO0DODULDVXUYHLOODQFH8QLWHG6WDWHV
0RJL * 5DPSHQJDQ 7+ 7KH HIILFDF\ RI VXOSKDWH TXLQLQH
compared to fansidar in treating falciparum malaria in children
4. Rampengan TH. Malaria pada anak. In: Harijanto PN, edi-
PRQWKV\HDUVROG3HGLDWU,QGRQHV
tor. Malaria epidemiologi, patogenesis, manifestasi klinis dan
0DURXVKHN65$JXLODU($V\PSWRPDWLFPDODULDLQ/LEHULDQ
SHQDQJDQDQ-DNDUWD(*&S
5. Krause PJ. Malaria (Plasmodium). In : Behrman RE, Klegman
&KRQJVXSKDMDLVLGGKL 7 0DODULD LQSDHGLDWULFSUDFWLFH,Q
50-HQVRQ+%HGLWRUV1HOVRQ7H[WERRNRI3HGLDWULFVWK
Wernsdorfer WH, McGregor I. editors. Malaria principles
HG3KLODGHOSKLD:%6DXQGHUV&RS
DQGSUDFWLFHRIPDODULRORJ\1HZ<RUN&KXUFKLOO/LYLQJVWRQH
6. Kundu R, Ganguly N, Ghosh TK, Choudhury P, Shah R.
Diagnosis and treatment malaria in child. Indian Pediatric
9DQ GHQ %URHN ,9 0DXQJ 8$ 3HWHUV $ /LHP / .DPDO
M, Rahman M, et al. Efficacy of chloroquine+sulfadoxine-
7. Stauffer W, Fischer PR. Diagnosis and treatment of malaria
pyrimetamine, mefloquine + artesunate and artemether +
LQFKLOGUHQ&OLQ,QIHFW'LV
lumefantrine combination therapies to treat Plasmodium
8. Leder K, Weller PF. Epidemiology, pathogenesis, clinical
falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
IHDWXUHVDQGGLDJQRVLVRIPDODULD$YDLODEOHIURPXUOKWWS
9DQGHQ%URHN,$PVDOX5%DODVHJDUDP0+HSSOH3$OHPX
9. Attaran A, Barnes KI, Curtis C, d’Alessandro U,Fanello
E, Hussein EB, et al. Efficacy of two artemisinin combination
CI,Galinski MR, et al. WHO, the global fund, and medical
therapies for uncomplicated falciparum malaria in children
PDOSUDFWLFH LQ PDODULD WUHDWPHQW /DQFHW
under 5 years, Malakal, Upper Nile Sudan. Malaria Journal
6XQJNDU 6 3ULEDGL : 5HVLVWHQVL 3ODVPRGLXP IDOVLSDUXP
.RUDP.$$EXDNX%'XDK14XDVKLH1&RPSDUDWLYH
WHUKDGDSREDWREDWPDODULD0DM.HG,QGRQHV
efficacy of antimalarialdrugs including ACTs in the treatment
of uncomplicated malaria among children under 5 years in
5DPSHQJDQ-5DPSHQJDQ7+0DODULDWURSLNDSDGDDQDN
\DQJUHVLVWHQ,,WHUKDGDSIDQVLGDU0DM.HG,QGRQHV
7DPEDMRQJ ) 3HUEDQGLQJDQ HILNDVL NRPELQDVL NORURNXLQ
dan sulfadoksin-pirimetamin dengan artemeter dan sulfa-
5DPSHQJDQ-0XO\DQWR$.DXQDQJ('5DPSHQJDQ7+
doksin-pirimetamin pada pengobatan malaria tropika tanpa
Malaria tropika pada anak yang resisten II terhadap kina
komplikasi pada anak. (Thesis). Manado: Universitas Sam
VXOIDW0DM)DUPDNRORJLGDQ7HUDSL,QGRQHVLD
9RQ6HLGOHLQ/%RMDQJ.-RQHV3$UDQGRPL]HGFRQWUROOHG
'RUVH\*1MDPD'.DP\D05&DWWDPDQFKL$.\DED\LQ]H
trial of artemether benflumetol, a new antimalarial and py-
D, Gasasira A, et al 6XOIDGR[LQHS\ULPHWKDPLQH DORQH RU
rimetamine sulphadoxine in the treatment of uncomplicated
with amodiaquine or artesunate for treatment of uncom-
244Paediatr Indones, Vol. 48, No. 4, July 2008 Jose Meky Mandei et al: Artesunate and sulphadoxine-pyrimethamine vs artesunate and amodiaquine in falciparum malaria
plicated malaria: a longitudinal randomised trial. Lancet
$QJROD7UDQV56RF7URS0HG+\J
7MLWUD(2EDWDQWLPDODULD,Q+DULMDQWR31HGLWRU0DODULD
:RUOG+HDOWK2UJDQL]DWLRQ$VVHVPHQWRIWKHUDSLFHIILFDF\
epidemiologi, patogenesis, manifestasi klinik dan penan-
of antimalarial drugs for uncomplicated falciparum malaria.
JDQDQ&HWDNDQ,-DNDUWD3HQHUELW%XNX.HGRNWHUDQ(*&
*XWKPDQQ-3$PSXHUR-)RUWHV)YDQ2YHUPHLU&*DERX-
6KDSLUR 7$ *ROGEHUJ '( &KHPRWKHUDS\ RI SURWR]RDO
laud V, Tobback S, et al. Antimalarial efficacy of chloroquine,
infections: malaria. In: Brunton LL, Lazo JS, Parker KL edi-
amodiquine, sulphadoxine-pyrimetamine, and the combina-
tors. Goodman and Gilman’s the pharmacological basis of
tions of amodiaquine + artesunate and sulfadoxine-pyrimet-
WKHUDSHXWLFV 8QLWHG 6WDWHV RI $PHULFD 0F*UDZ+LOO &R
amine + artesunate in Huambo and Bie provinces, central
Paediatr Indones, Vol. 48, No. 4, July 2008245
Original Article Artigo Original Resposta Cronotrópica ao Teste Cardiopulmonar após o Uso de Cimetidina Effects of Cimetidine on Chronotropic Response to Cardiopulmonary Exercise Testing Gicela Risso Rocha, Ricardo Stein, Márcio R. Guimarães, Jorge Pinto Ribeiro Clínica Cardiométodo, Hospital Ernesto Dornelles, Hospital de Clínicas de Porto Alegre -UFRGS - Porto Alegre, RS
Behavioral Activation Is an Evidence-Based Treatment for Depression The online version of this article can be found at: can be found at: Behavior Modification Additional services and information for Behavioral Activation Is an Evidence- Based Treatment for Depression Peter Sturmey1 Abstract Recent reviews of evidence-based treatment for depression did not identify